Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-28

Clinical Trial Update: Sitagliptin for the Treatment of Type 2 Diabetes [Phase 4]

View source ↗

Summary

Clinical trial update for sitagliptin in type 2 diabetes (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN